MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuMAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinomaMageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBsMAGE-RING protein complexes comprise a family of E3 ubiquitin ligasesIdentification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1Androgen receptor molecular biology and potential targets in prostate cancerUpdated overview of current biomarkers in head and neck carcinomaRole of genetic detection in peritoneal washes with gastric carcinoma: The past, present and futureKAPtain in charge of multiple missions: Emerging roles of KAP1MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerMelanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survivalhnRNP K coordinates transcriptional silencing by SETDB1 in embryonic stem cellsThe mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cellsDifferential evolution of MAGE genes based on expression pattern and selection pressurePotential role for PAD2 in gene regulation in breast cancer cells.Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancerT cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancerFrequent MAGE mutations in human melanomaFunctional interaction between co-expressed MAGE-A proteinsNecdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligaseInhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repressionAn overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell linesIdentification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastomaCancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complexMAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damageCancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
P2860
Q21131200-0CE2E078-1E40-410E-A500-9960FD4AB4A4Q21134039-788DC2DE-272A-4F43-8DD9-2D6805CF630CQ24298306-E371A56E-3236-4946-AD01-8AB320AAE04AQ24300816-C9774D84-5E9D-417F-A7FE-0AFA6F1099C5Q24338624-AD4B200C-381B-4D22-8D53-4D4051900DD2Q24602861-3CD3424F-2E19-4BB0-9840-CD134BF42FD6Q26750659-9D6F599A-898C-43E9-BC68-49173A3B644FQ26753850-D9FA2A28-9968-470E-8D19-5F98C4D812DDQ26822740-5E575BA1-C909-4A32-96E5-C076DD87C36DQ28478930-06987C36-FB7F-409F-B9EC-6605AACF5C24Q28483943-2479778C-72E5-462E-9F05-26F79F007859Q28543055-9E1EA13E-4299-4BCC-BE66-41DCD850F00EQ28586544-059997FA-09D1-49DE-8AB3-1AB35BEC6D44Q28714314-4AC785CD-6403-4F4A-9E63-FEEFDC2681BBQ28728858-096DF8BE-E9C3-4B7C-8F1D-D4A44BD67112Q33420388-DB65C81C-8E22-4981-9CF0-6005A8491139Q33530527-F6C02EC6-DB81-4988-B0C6-B3EBE1C4AB7DQ33598054-BBA54BC5-8C11-4CDB-BA51-0213F79013A5Q33700477-30723A7C-FAAE-4C67-A672-BB34B9FCE7C0Q33725090-38C896FF-C9CF-4F7C-A367-B9F8277CB2F3Q33727985-4093B824-AAC1-4B9A-8B6F-F4E77230A688Q33743831-64348C4B-766B-4459-9A4E-77C7FC4B4AE6Q33913833-E8B6A79F-168B-4FAF-9332-890B0AD2BFDBQ33957165-44D446E7-CDE6-4DCA-A9E6-C225890B46C9Q34005548-571F68A3-25F6-47EF-A590-AE1FA9A5C209Q34032518-FBE1A1B7-CD08-4463-B9AB-A71D08D7EC1CQ34081748-1558FDA7-ED74-413D-B487-EECD55880919Q34171827-473AB933-5E97-4D88-BDC7-E67DB1315A83Q34196069-AB65D8AF-19D3-48D7-B426-D6E836045B52Q34502501-2641868D-605B-4CE9-A06D-6FE3E8BE1101Q34592273-1F593D4E-2002-46AF-8219-E20042B36692Q34722558-9DDAB06F-3E59-4A4B-9D06-BC4A56867498Q34753747-57BFB8AE-BE56-4888-9587-0363933F36F2Q34981712-A14206B5-755D-44C6-A261-F25AB80CA238Q35091212-E9147158-AA7F-400F-8A80-CEC9B6E5758FQ35273882-177A36B3-FC6E-4E2C-985B-54CF34AAB5AFQ35543268-6A6532CB-0537-4680-A876-8B999A7AE4A0Q35637193-176D850E-862C-4FC6-BE9C-4007FC4E8344Q35786099-7D7A1374-BACB-4E6E-B0DD-EED4229ADA06Q35846167-3A6A4B32-1E25-4BA6-B735-EDC716D21827
P2860
MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
MAGE-A, mMage-b, and MAGE-C pr ...... s in MAGE-positive cell lines.
@en
type
label
MAGE-A, mMage-b, and MAGE-C pr ...... s in MAGE-positive cell lines.
@en
prefLabel
MAGE-A, mMage-b, and MAGE-C pr ...... s in MAGE-positive cell lines.
@en
P2093
P1433
P1476
MAGE-A, mMage-b, and MAGE-C pr ...... s in MAGE-positive cell lines.
@en
P2093
Alexey V Ivanov
Andrew J G Simpson
B Jack Longley
Claudia Gravekamp
F Michael Hoffmann
Hongzhuang Peng
Jianqiang Wu
Kumar M R Bhat
Noel Peters
P304
P356
10.1158/0008-5472.CAN-07-1478
P407
P577
2007-10-01T00:00:00Z